[go: up one dir, main page]

DE60006660D1 - Verwendung eines bestimmten hyaluronidases zur entfernung von hornhautnarbengewebe, trübung und schleier - Google Patents

Verwendung eines bestimmten hyaluronidases zur entfernung von hornhautnarbengewebe, trübung und schleier

Info

Publication number
DE60006660D1
DE60006660D1 DE60006660T DE60006660T DE60006660D1 DE 60006660 D1 DE60006660 D1 DE 60006660D1 DE 60006660 T DE60006660 T DE 60006660T DE 60006660 T DE60006660 T DE 60006660T DE 60006660 D1 DE60006660 D1 DE 60006660D1
Authority
DE
Germany
Prior art keywords
corneal
cornal
veil
turbidity
removal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60006660T
Other languages
English (en)
Other versions
DE60006660T2 (de
Inventor
Hampar Karageozian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISTA Pharmaceuticals Inc
Original Assignee
ISTA Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISTA Pharmaceuticals Inc filed Critical ISTA Pharmaceuticals Inc
Application granted granted Critical
Publication of DE60006660D1 publication Critical patent/DE60006660D1/de
Publication of DE60006660T2 publication Critical patent/DE60006660T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cereal-Derived Products (AREA)
DE60006660T 1999-04-29 2000-04-28 Verwendung eines bestimmten hyaluronidases zur entfernung von hornhautnarbengewebe, trübung und schleier Expired - Fee Related DE60006660T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13155899P 1999-04-29 1999-04-29
US131558P 1999-04-29
PCT/US2000/011369 WO2000066139A2 (en) 1999-04-29 2000-04-28 Biochemical methods that eliminate corneal scars, opacification and haze

Publications (2)

Publication Number Publication Date
DE60006660D1 true DE60006660D1 (de) 2003-12-24
DE60006660T2 DE60006660T2 (de) 2004-09-30

Family

ID=22449978

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60006660T Expired - Fee Related DE60006660T2 (de) 1999-04-29 2000-04-28 Verwendung eines bestimmten hyaluronidases zur entfernung von hornhautnarbengewebe, trübung und schleier

Country Status (13)

Country Link
US (1) US6737075B2 (de)
EP (1) EP1173198B1 (de)
JP (1) JP2002543143A (de)
AT (1) ATE254471T1 (de)
AU (1) AU4672300A (de)
CA (1) CA2370504A1 (de)
DE (1) DE60006660T2 (de)
DK (1) DK1173198T3 (de)
ES (1) ES2209877T3 (de)
HK (1) HK1045645A1 (de)
MX (1) MXPA01011025A (de)
PT (1) PT1173198E (de)
WO (1) WO2000066139A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7061237B2 (en) * 2000-07-13 2006-06-13 The Regents Of The University Of California Remote NMR/MRI detection of laser polarized gases
ES2325681T3 (es) 2000-10-13 2009-09-14 The Johns Hopkins University Activador de plasminogeno para prevenir turbidez corneal y subepitelial despues de cirugia de correccion de la vision con laser.
US6902548B1 (en) * 2001-03-19 2005-06-07 Ed Schuler Use of Streptomyces hyalurolyticus enzyme in ophthalmic treatments
US7156859B2 (en) 2001-07-23 2007-01-02 Fos Holding S.A. Device for separating the epithelium layer from the surface of the cornea of an eye
JP3921375B2 (ja) * 2001-10-12 2007-05-30 株式会社ニデック 眼科装置及び角膜手術装置
GB2389123B (en) 2002-05-29 2005-08-17 Unilever Plc Rechargeable dispensing device
SG177008A1 (en) 2003-03-05 2012-01-30 Halozyme Inc Soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceutical compositions comprising thereof
US7703919B2 (en) * 2003-03-28 2010-04-27 Digital Vision, Llc Application of neuro-ocular wavefront data in vision correction
JP2007503902A (ja) * 2003-09-05 2007-03-01 サイトレイト ビー．ブイ． 角膜上皮の分離装置
MXPA03011987A (es) 2003-12-19 2005-06-23 Osio Sancho Alberto Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
AU2006201459B2 (en) * 2005-04-08 2012-08-09 Theodore Coroneo Minas Corneal shaping
EP2004209B1 (de) * 2006-04-13 2013-07-24 Euclid Systems Corporation Zusammensetzung und verfahren zur stabilisierung des hornhautgewebes nach einem refraktiven chirurgischen eingriff
JP4871024B2 (ja) * 2006-05-26 2012-02-08 スター・ジャパン株式会社 眼内挿入用レンズの挿入器具
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
KR102114111B1 (ko) 2012-08-10 2020-05-25 오시오 코포레이션 디/비/에이 율리아 헬스 안과적 상태 치료시의 컨택트 렌즈 사용
WO2015073397A1 (en) 2013-11-13 2015-05-21 Thixos Llc Devices, kits and methods relating to treatment of facet joints
CN105079809A (zh) * 2015-07-09 2015-11-25 广州赛莱拉干细胞科技股份有限公司 组合物、制剂、制剂的制备方法、应用及使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4174389A (en) * 1977-05-13 1979-11-13 Cope Louise A Ophthalmic use of collagenase
US5270051A (en) * 1991-10-15 1993-12-14 Harris Donald H Enzyme-orthokeratology
US5788957A (en) * 1991-10-15 1998-08-04 Advanced Corneal Systems, Inc. Enzyme-orthokeratology
DE4214215A1 (de) * 1992-04-30 1993-11-04 Behringwerke Ag Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen
US5866120A (en) * 1995-11-22 1999-02-02 Advanced Corneal Systems, Inc. Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
DK0983084T3 (da) * 1997-05-22 2007-05-07 Ista Pharmaceuticals Inc Anvendelse af hyaluronidase til fremstilling af et öjenpræparat til flydendegörelse af glaslegemet i behandlingen af öjenlidelser

Also Published As

Publication number Publication date
ATE254471T1 (de) 2003-12-15
DE60006660T2 (de) 2004-09-30
WO2000066139A2 (en) 2000-11-09
US20020119141A1 (en) 2002-08-29
WO2000066139A3 (en) 2001-03-08
JP2002543143A (ja) 2002-12-17
EP1173198B1 (de) 2003-11-19
AU4672300A (en) 2000-11-17
ES2209877T3 (es) 2004-07-01
EP1173198A2 (de) 2002-01-23
MXPA01011025A (es) 2002-11-07
CA2370504A1 (en) 2000-11-09
US6737075B2 (en) 2004-05-18
DK1173198T3 (da) 2004-04-13
HK1045645A1 (zh) 2002-12-06
PT1173198E (pt) 2004-04-30

Similar Documents

Publication Publication Date Title
DE60006660D1 (de) Verwendung eines bestimmten hyaluronidases zur entfernung von hornhautnarbengewebe, trübung und schleier
Wang et al. Comparison of laser in situ keratomileusis and photorefractive keratectomy to correct myopia from-1.25 to-6.00 diopters
Mastropasqua et al. Photorefractive keratectomy with aspheric profile of ablation versus conventional photorefractive keratectomy for myopia correction: six-month controlled clinical trial
Ibrahim Laser in situ keratomileusis for hyperopia and hyperopic astigmatism
Ayala et al. Treatment of laser in situ keratomileusis interface epithelial ingrowth with neodymium: yytrium–aluminum–garnet laser
ATE286880T2 (de) Verwendung von fluprostenolisopropylester zur herstellung eines arzneimittels zur behandlung von glaukom und okularer hypertension
DE60126435D1 (de) Apparat zur behandlung von presbyopie und anderer augenerkrankungen mit faser-gekoppelten lasern
Pallikaris et al. Laser in situ keratomileusis intraoperative complications using one type of microkeratome
Kapadia et al. Transepithelial photorefractive keratectomy for treatment of thin flaps or caps after complicated laser in situ keratomileusis
Mortensen et al. Excimer laser surgery for keratoconus
Lane et al. Prophylactic use of mitomycin-C in the management of a buttonholed LASIK flap
Bilgihan et al. Excimer laser-assisted anterior lamellar keratoplasty for keratoconus, corneal problems after laser in situ keratomileusis, and corneal stromal opacities
Peters et al. Minimizing the risk of recutting with a Hansatome over an existing Automated Corneal Shaper flap for hyperopic laser in situ keratomileusis enhancement
RU2020908C1 (ru) Способ коррекции близорукости
RU2121328C1 (ru) Способ хирургической коррекции миопии высокой степени
Fraenkel et al. Paradoxical response to photorefractive treatment for postkeratoplasty astigmatism
RU2228730C1 (ru) Способ устранения близорукости высокой степени при наличии тонкой роговицы
Abad et al. Corneal collagen cross-linking induced by UVA and riboflavin (CXL)
DE60027878D1 (de) Verwendung des nervenwachstumfaktors zur herstellung eines arzneimittels zur behandlung von erkrankungen der innenaugegeweb
KR930021214A (ko) 안질환의 치료 또는 예방을 위한 제약학적 조성물
CN208145079U (zh) 一种新型人工临时眼角膜
RU2256430C1 (ru) Способ имплантации внутрироговичной линзы
Lee et al. Amniotic membrane as a biologic pressure patch for treating epithelial ingrowth under a damaged laser in situ keratomileusis flap
US6146405A (en) Ophthalmic applanator
RU2189209C1 (ru) Модифицированный способ проведения лазерного кератомилеза

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee